Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Julie Kanter, MD
Researcher Associate Professor
Division of Hematology & Oncology
University of Alabama School of Medicine
1720 2nd Avenue South, NP 2540
Birmingham, Alabama, United States
Dr. Julie Kanter is the Associate Professor of hematology and oncology and Director of the Comprehensive Sickle Cell Center at the University of Alabama at Birmingham. Her academic focus is on improving the comprehensive care of persons with sickle cell disease throughout the lifespan and clinical and translational research to better understand and address issues in treatment and prevention in sickle cell disease.
Prior to moving to Alabama, Dr. Kanter was the Director of sickle cell disease research and Associate Professor of Pediatrics at the Medical University of South Carolina. Dr. Kanter is very committed to improving outcomes in sickle cell disease and ensuring those outcomes reach the affected individuals. She works closely with national partners including the American Society of Hematology and the NIH on both advocacy and research.
Board Certification:
– Pediatrics: Pediatric Hematology-Oncology
Specialties:
– Pediatric Hematology/Oncology
– Cancer
– Pediatric
Representative Publications:
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events
+myBinderRelated Content
-
A Patient Advocate’s Take on Sickle Cell Disease: The Pain and the PromiseSeptember is National Sickle Cell Awaren...
-
The Comprehensive Sickle Cell Center at Children’s Hospital of PhiladelphiaThe Comprehensive Sickle Cell Center at ...
-
Sanjay J. Shah, MDDr. Sanjay J. Shah currently works for P...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...
-
Building Access to Care in Adult Sickle Cell Disease: Defining Models of Care, Essential Components, and Economic As...Sickle cell disease (SCD) is the most co...
-
High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after trans...BACKGROUND: Chronic blood transfusion is...
-
Jo Howard, MB BChir, MRCP, FRCPathJo Howard, MB BChir, MRCP, FRCPath, beca...
